Quanterix granted breakthrough device designation from U.S. FDA for NfL test for multiple sclerosis

22 April 2022 - Blood based assay has the potential to serve the multiple sclerosis community in management of relapsing-remitting form ...

Read more →

Bridge to Life receives breakthrough device designation from the FDA

21 April 2022 - Bridge to Life advances their perfusion system development with the breakthrough device designation for the LifeCradle ...

Read more →

What counts as a breakthrough? 8 insights on the FDA’s approach to medical devices.

21 April 2022 - The word breakthrough carries a kind of weight: it’s a dramatic step forward, a critical advance in ...

Read more →

New drug application resubmission update

20 April 2022 - Polarean Imaging announces that further to the RNS issued on 31 March 2022, the Company can confirm ...

Read more →

Cook Medical receives FDA breakthrough device designation for Zenith Thoraco+ endovascular system

31 March 2022 - Cook Medical’s Zenith Thoraco+ endovascular system (Thoraco+) has received breakthrough device Designation from the US FDA.  ...

Read more →

Insightec receives FDA IDE approval and breakthrough designation for NSCLC brain mets study

9 March 2022 - Designation and approvals mark key milestones in advancing Insightec blood brain barrier clinical roadmap using acoustic ...

Read more →

Saluda Medical receives FDA approval for the Evoke spinal cord stimulation system to treat chronic intractable pain

8 March 2022 - Evoke system deemed superior to open loop spinal cord stimulation in treating overall back and leg pain. ...

Read more →

Merit Medical receives FDA breakthrough device designation for Embosphere microspheres for use in genicular artery embolisation for symptomatic knee osteoarthritis

7 March 2022 - Merit Medical Systems announced today that it has received breakthrough device designation from the U.S. FDA ...

Read more →

AltPep receives FDA breakthrough device designation for SOBA-AD, a simple blood test for the detection of Alzheimer’s disease

1 March 2022 - AltPep Corporation today announced the U.S. FDA granted the company breakthrough device designation for its SOBA-AD diagnostic ...

Read more →

Minimally invasive epilepsy treatment EASEE receives FDA breakthrough device designation

21 February 2022 - Precisis has received breakthrough device designation from the U.S. FDA for its EASEE brain stimulator. FDA’s ...

Read more →

Noninvasix receives FDA breakthrough device designation for non-invasive monitoring technology for sepsis

23 February 2022 - LIVOx is first monitoring device to non-invasively monitor sepsis by detecting a key indicator of septic ...

Read more →

FDA permits marketing of first condom specifically indicated for anal intercourse

23 February 2022 - Other FDA cleared condoms can continue to be used for contraception and to prevent sexually transmitted infections. ...

Read more →

Medtronic receives FDA approval for InterStim X system, the next generation of the most personalised sacral nerve stimulation therapy for bladder and bowel control

22 December 2022 - New InterStim X system provides 10 to 15 years of battery life without the need to recharge. ...

Read more →

NeuroSigma receives FDA breakthrough device designation for Monarch eTNS system

22 February 2022 - Monarch eTNS recognised as novel device for drug resistant epilepsy. ...

Read more →

Bonalive Biomaterials granted FDA breakthrough device designation for a bone graft substitute that potentially protects against microbial colonisation

16 February 2022 - The Center for Devices and Radiological Health at the U.S. FDA has determined that Bonalive Orthopedics granules, ...

Read more →